Last edition
News about Market
EU Grants Conditional Approval to Rezurock for Chronic GVHD Treatment
European Commission authorises belumosudil for patients aged 12 plus with limited treatment options, marking a significant advance in managing a life-threatening post-transplant condition.
Market | 01/04/2026 | By News Bureau | 147
Freudenberg Reports INR 4,427 Crore Sales, Emerges as Key Growth Driver
Freudenberg reports €11.73B in sales and €1.09B operating profit, highlighting strong financial performance with continued investments in R&D and AI-driven innovation with an investment of €200 million by 2028.
Market | 01/04/2026 | By News Bureau | 265
Biogen to Acquire Apellis, Expands Immunology and Rare Disease Portfolio
Biogen to acquire Apellis for USD 5.6 billion, adding EMPAVELI and SYFOVRE to expand its immunology, rare disease and nephrology portfolio and drive long-term growth.
Market | 01/04/2026 | By News Bureau | 200
Meiji Seika Pharma Invests in Centivax for Universal Vaccine Platform
Meiji Seika Pharma invests in Centivax to advance a next-generation universal vaccine platform, with lead candidate Centi-Flu 01 currently in a Phase 1 influenza study.
Market | 31/03/2026 | By News Bureau | 117
Biocytogen Grants Licence for RenNano Platform to Taisho Pharmaceutical
Biocytogen licenses its RenNano platform to Taisho Pharmaceutical to advance fully human heavy chain-only antibody discovery, supporting in-vivo screening and downstream research.
Market | 31/03/2026 | By News Bureau | 195
ELMED Life Sciences Raises USD 2.7 Million to Scale Probiotic Manufacturing and Global Expansion
ELMED Life Sciences, a science-driven company specializing in probiotic and biological solutions, has raised USD 2.7 million (approximately INR 25 crore) in a Series A funding round led by AgriSURE Fund, managed by NABVENTURES.
Market | 26/03/2026 | By Darshana | 209
Against this backdrop, Integris MedTech has distinguished itself among Indian peers through its execution speed, disciplined integration approach, and ability to translate acquisitions into scalable market access rather than isolated capacity expansion. Its strategy aligns well with the broader industry shift toward platform-driven growth.
Market | 26/03/2026 | By Darshana | 132
Endogenex Raises USD 50 Million to Advance Novel Diabetes Treatment
Series C extension led by Arboretum Ventures to fund pivotal clinical study and support regulatory pathway for ReCET System.
Market | 26/03/2026 | By News Bureau | 275
PMDA Expands Use of Enhertu for Second-Line Gastric Cancer in Japan
Regulatory update allows Enhertu to be used earlier in treatment for HER2-positive advanced gastric cancer, backed by phase III data showing improved survival outcomes.
Market | 25/03/2026 | By News Bureau | 404
Bio-Thera Expands Partnership with Intas for BAT2506 Biosimilar in India
Bio-Thera has expanded its partnership with Intas Pharmaceuticals to commercialise BAT2506, a proposed golimumab biosimilar, in India.
Market | 24/03/2026 | By News Bureau | 236
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy